Thursday, October 29, 2009
6-8 p.m.
A.I. Johnson Great Room, McNamara Alumni Center
200 Oak St. S.E.
Minneapolis, MN 55455
Map and directions

University of Minnesota researchers will present information and answer questions about the prostate-specific antigen (PSA) test for prostate cancer.

PSA is a substance made by the prostate gland, and it may be found in increased amounts in men with prostate cancer. Other prostate problems can also produce higher levels, such as benign enlargement which often occurs as men age.

Recent studies, including the Prostate, Lung, Colorectal and Ovarian (PLCO) screening study, looked at whether or not men who were screened with a PSA blood test had a better outcome than those who did not have the PSA screening. The PLCO screening study did not show an advantage to using PSA for screening.

In this presentation we will look at what we know about the use of PSA in prostate cancer screening, diagnosis, and treatment.

Program

Welcome and Introductions

Marva Bohen, M.S., R.N.
Director, Outreach and Education
Masonic Cancer Center, University of Minnesota

 

 

 

Presentations followed by questions and answers

Prostate Cancer Screening and PSA: What Do We Know?
Timothy Church, Ph.D.
Professor, Department of Environmental Health Sciences, University of Minnesota School of Public Health
Member, Masonic Cancer Center Prevention and Etiology Research Program
Principal Investigator for the PLCO study

Using PSA in Prostate Cancer Diagnosis and Treatment
Christopher Warlick, M.D., Ph.D.
Urologic Surgeon
Assistant Professor, Urologic Surgery, University of Minnesota Medical School
Masonic Cancer Center Member

Registration

There is no cost for this program but pre-registration is requested.

Register online
or call 612-624-2620 or toll-free in IA, MN, ND, SD, WI: 1-888-CANCER MN (1-888-226-2376).

Cancer U: Ask the Experts events are offered as a community service to provide cancer patients, survivors, caregivers, and others interested in learning more about cancer with an opportunity to get accurate information about cancer from University cancer researchers and physicians.